Skip to main content
1-877-936-8422
VICC
Search
Main navigation
Home
Patient Care
Cancer Care Overview
Find a Doctor
Request an Appointment
Find a Clinical Trial
MyHealth at Vanderbilt
Support & Education
Cancer Information
Clinical Trials
Clinical Trials Overview
Frequently Asked Questions
Trial Search for Physicians
Trial Search For Patients
Flowcharts
Research
Research Overview
Research Programs
Shared Resources
Clinical Trials
Member Directory
Membership Information
Funding Opportunities
Giving
Giving & Impact
Make a Gift
Donor-Supported Research
Volunteer
Community
Community Overview
Advocacy
VICC Ambassadors
Cancer InFocus
Education
Education, Training, and Career Development
Annual Scientific Retreat
About
About Vanderbilt-Ingram
Leadership
Fast Facts
History
Careers
For Media
More
Intranet (for faculty and staff)
About the site
Help
Contact the web team
Prices
Search
at Vanderbilt-Ingram Cancer Center
Site Search
All
Pages
Members
Clinical Trials
News
1262 results found
pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS1, hrHPV+ Oropharyngeal Cancer
Relevance:
1
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Relevance:
1
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Relevance:
1
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Relevance:
1
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Relevance:
1
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
Relevance:
1
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Relevance:
1
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Relevance:
1
Phase II Panitumumab-IRDye800 in Head & Neck Cancer
Relevance:
1
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Relevance:
1
Pagination
Previous page
‹ previous
…
Page
55
Page
56
Page
57
Page
58
Current page
59
Page
60
Page
61
Page
62
Page
63
…
Next page
next ›